The Effectiveness of Repeat Celiac Plexus Neurolysis for Pancreatic Cancer: A Pilot Study

Pain Practice

Volumn 13, Issue 2, 2013, Pages 89-95

  Mcgreevy, Kai ^a   Hurley, Robert W ^b   Erdek, Michael A ^a   Aner, Musa M ^c   Li, Sean ^a   Cohen, Steven P ^a,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Celiac plexus; Malignant pain; Neurolysis; Pancreatic cancer

Indexed keywords

BUPIVACAINE; LIDOCAINE;

ADULT; ANALGESIA; ARTICLE; CANCER GROWTH; CANCER PAIN; CANCER SURGERY; CELIAC PLEXUS NEUROLYSIS; CLINICAL ARTICLE; FEMALE; HUMAN; LOCAL ANESTHESIA; MALE; NEUROLYSIS; PANCREAS CANCER; PARALLEL DESIGN; PILOT STUDY; TREATMENT OUTCOME;

EID: 84873450781     PISSN: 15307085     EISSN: 15332500     Source Type: Journal    
DOI: 10.1111/j.1533-2500.2012.00557.x     Document Type: Article

References (13)

1. Hidalgo M. Pancreatic cancer. N Engl J Med. 2010;362:1605-1617.
2. Kelsen DP, Portenoy R, Thaler H, Tao Y, Brennan M. Pain as a predictor of outcome in patients with operable pancreatic carcinoma. Surgery. 1997;122:53-59.
3. Staats PS, Hekmat H, Sauter P, Lillemoe K. The effects of alcohol celiac plexus block, pain, and mood on longevity in patients with unresectable pancreatic cancer: a double-blind, randomized, placebo-controlled study. Pain Med. 2001;2:28-34.
4. Budisin NI, Majdevac IZ, Budisin ES, Manic D, Patrnoqic A, Radovanovic Z. Surgery for patients with gastric cancer in the terminal stage of the illness-TNM stage IV. J Buon. 2009;14:593-603.
5. Wong GY, Schroeder DR, Carns PE, et al.Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: a randomized controlled trial. JAMA. 2004;291:1092-1099.
6. Ischia S, Ischia A, Polati E, Finco G. Three posterior percutaneous celiac plexus block techniques. A prospective, randomized study in 61 patients with pancreatic cancer pain. Anesthesiology. 1992;76:534-540.
7. Eisenberg E, Carr DB, Chalmers TC. Neurolytic celiac plexus block for treatment of cancer pain: a meta-analysis. Anesth Analg. 1995;80:290-295.
8. Rykowski JJ, Hilgier M. Efficacy of neurolytic celiac plexus block in varying locations of pancreatic cancer: influence on pain relief. Anesthesiology. 2000;92:347-354.
9. Arcidiacono PG, Calori G, Carrara S, McNicol ED, Testoni PA. Celiac plexus block for pancreatic cancer pain in adults. Cochrane Database Syst Rev. 2011;3:CD007519.
10. Erdek MA, Halpert DE, González Fernández M, Cohen SP. Assessment of celiac plexus block and neurolysis outcomes and technique in the management of refractory visceral cancer pain. Pain Med. 2010;11:92-100.
11. De Cicco M, Matovic M, Bortolussi R, et al.Celiac plexus block: injectate spread and pain relief in patients with regional anatomic distortions. Anesthesiology. 2001;94:561-565.
12. Kaptchuk TJ, Stason WB, Davis RB, et al.Sham device v inert pill: randomized controlled trial of two placebo treatments. BMJ. 2006;332:391-397.
13. Koshi EB, Short CA. Placebo theory and its implications for research and clinical practice: a review of the recent literature. Pain Pract. 2007;7:4-20.